NS SPEAKS has been here for 19 years for people interested in multiple sclerosis

News:

Create A Forum Installed

  3. Recent Posts

Recent Posts

Pages: 1 ... 4 5 [6] 7 8 ... 10
51
THE PRACTICAL SIDE OF BEING MULTIPLY SCLEROSED / For-profit nursing home facilities are risky
« Last post by agate on February 02, 2026, 10:51:37 am »
From Just Care (December 16, 2025):

Nursing Home Residents in For-Profit Facilities Continue to Face Grave Risks
52
THE PRACTICAL SIDE OF BEING MULTIPLY SCLEROSED / Standing on one leg to improve balance
« Last post by agate on February 01, 2026, 09:20:32 pm »
From the BBC (January 15, 2026)--"The surprising benefits of standing on one leg":


https://www.bbc.com/future/article/20260114-the-surprising-benefits-of-standing-on-one-leg
53
MS - RESEARCH AND NEWS / (Abst.) Violence in MS: Towards an evidence-informed call to action in neurology
« Last post by agate on January 31, 2026, 09:24:53 pm »
From Multiple Sclerosis Journal (January 21, 2026)--"Violence in multiple sclerosis: Towards an evidence-informed call to action in neurology":


10.1177/13524585251409580
54
NEWS / Hundreds of Minnesota MDs speak out against ICE tactics (New England Journal of Medicine)
« Last post by agate on January 30, 2026, 08:23:45 am »
From the Correspondence section of the New England Journal of Medicine (January 29, 2026), a letter entitled "We Do Care," written by a doctor and with an appendix showing that over 580 Minnesota doctors have signed the letter.


https://www.nejm.org/doi/full/10.1056/NEJMc2601288?query=RP#ap1
55
MS - RESEARCH AND NEWS / January 2026 MSAA Research Update
« Last post by agate on January 29, 2026, 09:23:27 am »
MSAA Research Update - January 2026:


What's New in MS Research - January 2026
56
MS - RESEARCH AND NEWS / Commentary on MS controversy: Targeting EBV is a viable therapeutic strategy in MS
« Last post by agate on January 29, 2026, 06:00:19 am »

The Multiple Sclerosis Journal often has a section for two brief articles taking opposing sides on a controversial issue, followed by a brief commentary summarizing the discussion. This is the Commentary section on this question


From Multiple Sclerosis Journal (January 21, 2026)--"Controversies in multiple sclerosis: Targeting EBV is a viable therapeutic strategy in MS--Commentary":


https://journals.sagepub.com/doi/full/10.1177/13524585251409951
57
POLITICS / (MedPage Today Perspective) Nurse Alex Pretti's death and the symbolism of the human body
« Last post by agate on January 27, 2026, 04:42:11 pm »

From MedPage Today (January 26, 2026):
Nurse Alex Pretti's death and the symbolism of the human body
58
MS - RESEARCH AND NEWS / Priorities for how future MS research in Canada considers equity, diversity, inclusion
« Last post by agate on January 26, 2026, 08:57:29 pm »

From Multiple Sclerosis Journal (January 20, 2026)--"Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity, and inclusion: A  modified e-Delphi study":


https://journals.sagepub.com/doi/full/10.1177/20552173251398975
59
MS - RESEARCH AND NEWS / (Abst.) Cognitive reserve and its contribution to predicting cognitive performance in MS
« Last post by agate on January 25, 2026, 08:53:26 pm »
From PubMed (January 25, 2026)--"Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/41579714/
60
TREATMENTS / FDA fails to approve tolebrutinib for MS
« Last post by agate on January 24, 2026, 09:52:41 am »
Seems there was a case of liver damage where the person died.


The FDA has turned thumbs-down on tolebrutinib for MS.


https://www.fiercebiotech.com/biotech/fda-cites-severe-liver-injury-risk-unclear-benefit-behind-sanofis-ms-drug-rejection
Pages: 1 ... 4 5 [6] 7 8 ... 10